Enric Pedrol

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Goodpasture's disease in the elderky: A case report

Goodpasture's disease in the elderky: A case report

Journal: Revista espanola de geriatria y gerontologia

Published: April 02, 2020

Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients.

Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients.

Journal: Frontiers in genetics

Published: June 26, 2019

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study.

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study.

Journal: HIV clinical trials

Published: March 18, 2015

Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicity.

Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicity.

Journal: The Journal of antimicrobial chemotherapy

Published: November 12, 2014

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.

Journal: HIV medicine

Published: October 09, 2014

Reasons for antiretroviral treatment change in HIV+ patients in Spain in 2010-2011. SWITCH AUDIT Study

Reasons for antiretroviral treatment change in HIV+ patients in Spain in 2010-2011. SWITCH AUDIT Study

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: June 19, 2014

Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

Journal: Enfermedades infecciosas y microbiologia clinica

Published: May 05, 2014

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

Journal: Enfermedades infecciosas y microbiologia clinica

Published: May 05, 2014

Human immunodeficiency virus and emergency departments. Reply

Human immunodeficiency virus and emergency departments. Reply

Journal: Enfermedades infecciosas y microbiologia clinica

Published: November 12, 2013

Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.

Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.

Journal: HIV clinical trials

Published: October 23, 2013

Reasons for the introduction of darunavir in the antirretroviral treatment in HIV-infected patients

Reasons for the introduction of darunavir in the antirretroviral treatment in HIV-infected patients

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: July 03, 2013

A cross-sectional epidemiological study of chronic HCV liver disease stage in HIV-coinfected patients using noninvasive techniques: CoTrans- GEENI Study.

A cross-sectional epidemiological study of chronic HCV liver disease stage in HIV-coinfected patients using noninvasive techniques: CoTrans- GEENI Study.

Journal: Current HIV research

Published: March 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026